# Regeneron Pharmaceuticals net income entity: /record/regeneron-pharmaceuticals.md predicate: net_income page: /record/regeneron-pharmaceuticals/net_income as_of: 2026-11-09 cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: 1,948,700,000 United States dollar", as of 2026-09-30. Claim clm_DEF587D6916A, https://asof.is/claim/clm_DEF587D6916A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm. As of November 9, 2026, the latest net income figure on the AsOf record for Regeneron Pharmaceuticals is $1.95 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Regeneron Pharmaceuticals's latest full-year net income is $4.5 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 18 claims on Regeneron Pharmaceuticals's net income, 1 open and 17 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest net income The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_net_income claim, kept apart from the full-year series. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,948,700,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DEF587D6916A](/claim/clm_DEF587D6916A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm ## Latest full-year net income What the record asserts on 2026-11-09. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,504,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -79,129,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_4BD3F29C30C3](/claim/clm_4BD3F29C30C3.md) | [clm_7DFF0FB9DC16](/claim/clm_7DFF0FB9DC16.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -67,830,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_9855FD3A29B1](/claim/clm_9855FD3A29B1.md) | [clm_4BD3F29C30C3](/claim/clm_4BD3F29C30C3.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -104,468,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_F3AAA9683DBE](/claim/clm_F3AAA9683DBE.md) | [clm_9855FD3A29B1](/claim/clm_9855FD3A29B1.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | -221,760,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_2F265702ECB5](/claim/clm_2F265702ECB5.md) | [clm_F3AAA9683DBE](/claim/clm_F3AAA9683DBE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 750,269,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_945579B45ED0](/claim/clm_945579B45ED0.md) | [clm_2F265702ECB5](/claim/clm_2F265702ECB5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217613000004/0001532176-13-000004-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 424,362,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_D3F5BB8C7757](/claim/clm_D3F5BB8C7757.md) | [clm_945579B45ED0](/claim/clm_945579B45ED0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 348,074,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_65C9343FBB71](/claim/clm_65C9343FBB71.md) | [clm_D3F5BB8C7757](/claim/clm_D3F5BB8C7757.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217615000008/0001532176-15-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 636,056,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_AFF68BBC35BE](/claim/clm_AFF68BBC35BE.md) | [clm_65C9343FBB71](/claim/clm_65C9343FBB71.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 895,522,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_DC0177CB2929](/claim/clm_DC0177CB2929.md) | [clm_AFF68BBC35BE](/claim/clm_AFF68BBC35BE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 1,198,511,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_FCBDA03CE99C](/claim/clm_FCBDA03CE99C.md) | [clm_DC0177CB2929](/claim/clm_DC0177CB2929.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 2,444,400,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_272E08FDAC9C](/claim/clm_272E08FDAC9C.md) | [clm_FCBDA03CE99C](/claim/clm_FCBDA03CE99C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217619000009/0001532176-19-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 2,115,800,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_0AB6F3A48383](/claim/clm_0AB6F3A48383.md) | [clm_272E08FDAC9C](/claim/clm_272E08FDAC9C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000153217620000008/0001532176-20-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 3,513,200,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_D26172E0F6F8](/claim/clm_D26172E0F6F8.md) | [clm_0AB6F3A48383](/claim/clm_0AB6F3A48383.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 8,075,300,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_2FCCACC23EDE](/claim/clm_2FCCACC23EDE.md) | [clm_D26172E0F6F8](/claim/clm_D26172E0F6F8.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/0001804220-22-000007-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,338,400,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_11400CA0B8A6](/claim/clm_11400CA0B8A6.md) | [clm_2FCCACC23EDE](/claim/clm_2FCCACC23EDE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/0001804220-23-000008-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 3,953,600,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_4E27594C511A](/claim/clm_4E27594C511A.md) | [clm_11400CA0B8A6](/claim/clm_11400CA0B8A6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,412,600,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) | [clm_4E27594C511A](/claim/clm_4E27594C511A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,504,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm ## What replaced what - -$79.13 million (2008-12-31 to 2009-12-31, [clm_7DFF0FB9DC16](/claim/clm_7DFF0FB9DC16.md)) was replaced by -$67.83 million from 2009-12-31 ([clm_4BD3F29C30C3](/claim/clm_4BD3F29C30C3.md)) - -$67.83 million (2009-12-31 to 2010-12-31, [clm_4BD3F29C30C3](/claim/clm_4BD3F29C30C3.md)) was replaced by -$104.47 million from 2010-12-31 ([clm_9855FD3A29B1](/claim/clm_9855FD3A29B1.md)) - -$104.47 million (2010-12-31 to 2011-12-31, [clm_9855FD3A29B1](/claim/clm_9855FD3A29B1.md)) was replaced by -$221.76 million from 2011-12-31 ([clm_F3AAA9683DBE](/claim/clm_F3AAA9683DBE.md)) - -$221.76 million (2011-12-31 to 2012-12-31, [clm_F3AAA9683DBE](/claim/clm_F3AAA9683DBE.md)) was replaced by $750.27 million from 2012-12-31 ([clm_2F265702ECB5](/claim/clm_2F265702ECB5.md)) - $750.27 million (2012-12-31 to 2013-12-31, [clm_2F265702ECB5](/claim/clm_2F265702ECB5.md)) was replaced by $424.36 million from 2013-12-31 ([clm_945579B45ED0](/claim/clm_945579B45ED0.md)) - $424.36 million (2013-12-31 to 2014-12-31, [clm_945579B45ED0](/claim/clm_945579B45ED0.md)) was replaced by $348.07 million from 2014-12-31 ([clm_D3F5BB8C7757](/claim/clm_D3F5BB8C7757.md)) - $348.07 million (2014-12-31 to 2015-12-31, [clm_D3F5BB8C7757](/claim/clm_D3F5BB8C7757.md)) was replaced by $636.06 million from 2015-12-31 ([clm_65C9343FBB71](/claim/clm_65C9343FBB71.md)) - $636.06 million (2015-12-31 to 2016-12-31, [clm_65C9343FBB71](/claim/clm_65C9343FBB71.md)) was replaced by $895.52 million from 2016-12-31 ([clm_AFF68BBC35BE](/claim/clm_AFF68BBC35BE.md)) - $895.52 million (2016-12-31 to 2017-12-31, [clm_AFF68BBC35BE](/claim/clm_AFF68BBC35BE.md)) was replaced by $1.2 billion from 2017-12-31 ([clm_DC0177CB2929](/claim/clm_DC0177CB2929.md)) - $1.2 billion (2017-12-31 to 2018-12-31, [clm_DC0177CB2929](/claim/clm_DC0177CB2929.md)) was replaced by $2.44 billion from 2018-12-31 ([clm_FCBDA03CE99C](/claim/clm_FCBDA03CE99C.md)) - $2.44 billion (2018-12-31 to 2019-12-31, [clm_FCBDA03CE99C](/claim/clm_FCBDA03CE99C.md)) was replaced by $2.12 billion from 2019-12-31 ([clm_272E08FDAC9C](/claim/clm_272E08FDAC9C.md)) - $2.12 billion (2019-12-31 to 2020-12-31, [clm_272E08FDAC9C](/claim/clm_272E08FDAC9C.md)) was replaced by $3.51 billion from 2020-12-31 ([clm_0AB6F3A48383](/claim/clm_0AB6F3A48383.md)) - $3.51 billion (2020-12-31 to 2021-12-31, [clm_0AB6F3A48383](/claim/clm_0AB6F3A48383.md)) was replaced by $8.08 billion from 2021-12-31 ([clm_D26172E0F6F8](/claim/clm_D26172E0F6F8.md)) - $8.08 billion (2021-12-31 to 2022-12-31, [clm_D26172E0F6F8](/claim/clm_D26172E0F6F8.md)) was replaced by $4.34 billion from 2022-12-31 ([clm_2FCCACC23EDE](/claim/clm_2FCCACC23EDE.md)) - $4.34 billion (2022-12-31 to 2023-12-31, [clm_2FCCACC23EDE](/claim/clm_2FCCACC23EDE.md)) was replaced by $3.95 billion from 2023-12-31 ([clm_11400CA0B8A6](/claim/clm_11400CA0B8A6.md)) - $3.95 billion (2023-12-31 to 2024-12-31, [clm_11400CA0B8A6](/claim/clm_11400CA0B8A6.md)) was replaced by $4.41 billion from 2024-12-31 ([clm_4E27594C511A](/claim/clm_4E27594C511A.md)) - $4.41 billion (2024-12-31 to 2025-12-31, [clm_4E27594C511A](/claim/clm_4E27594C511A.md)) was replaced by $4.5 billion from 2025-12-31 ([clm_7514724ED5E9](/claim/clm_7514724ED5E9.md)) ## Questions this record answers ### What is Regeneron Pharmaceuticals's current net income? The latest figure on the record is $1.95 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $4.5 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was Regeneron Pharmaceuticals's net income for the quarter ended September 30, 2026? $1.95 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Regeneron Pharmaceuticals's net income last change? The latest value on the record is $4.5 billion, dated December 31, 2025; before it the record holds $4.41 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Regeneron Pharmaceuticals's net income before $4.5 billion? $4.41 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/regeneron-pharmaceuticals/net_income (markdown: /record/regeneron-pharmaceuticals/net_income.md) - Entity twin: /record/regeneron-pharmaceuticals.md ยท timeline: /timelines/regeneron-pharmaceuticals.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.